Masimo Total Liabilities 2010-2025 | MASI
Masimo total liabilities from 2010 to 2025. Total liabilities can be defined as the total value of all possible claims against the corporation.
- Masimo total liabilities for the quarter ending June 30, 2025 were $1.360B, a 10.84% decline year-over-year.
- Masimo total liabilities for 2024 were $1.574B, a 6.14% decline from 2023.
- Masimo total liabilities for 2023 were $1.677B, a 10.42% decline from 2022.
- Masimo total liabilities for 2022 were $1.872B, a 455.73% increase from 2021.
| Masimo Annual Total Liabilities (Millions of US $) |
|
|---|---|
| 2024 | $1,574 |
| 2023 | $1,677 |
| 2022 | $1,872 |
| 2021 | $337 |
| 2020 | $305 |
| 2019 | $228 |
| 2018 | $186 |
| 2017 | $181 |
| 2016 | $260 |
| 2015 | $326 |
| 2014 | $257 |
| 2013 | $112 |
| 2012 | $99 |
| 2011 | $86 |
| 2010 | $80 |
| 2009 | $67 |
| Masimo Quarterly Total Liabilities (Millions of US $) |
|
|---|---|
| 2025-06-30 | $1,360 |
| 2025-03-31 | $1,347 |
| 2024-12-31 | $1,574 |
| 2024-09-30 | $1,625 |
| 2024-06-30 | $1,525 |
| 2024-03-31 | $1,593 |
| 2023-12-31 | $1,677 |
| 2023-09-30 | $1,720 |
| 2023-06-30 | $1,703 |
| 2023-03-31 | $1,785 |
| 2022-12-31 | $1,872 |
| 2022-09-30 | $1,804 |
| 2022-06-30 | $1,758 |
| 2022-03-31 | $327 |
| 2021-12-31 | $337 |
| 2021-09-30 | $299 |
| 2021-06-30 | $290 |
| 2021-03-31 | $270 |
| 2020-12-31 | $305 |
| 2020-09-30 | $298 |
| 2020-06-30 | $291 |
| 2020-03-31 | $221 |
| 2019-12-31 | $228 |
| 2019-09-30 | $206 |
| 2019-06-30 | $190 |
| 2019-03-31 | $174 |
| 2018-12-31 | $186 |
| 2018-09-30 | $183 |
| 2018-06-30 | $182 |
| 2018-03-31 | $183 |
| 2017-12-31 | $181 |
| 2017-09-30 | $189 |
| 2017-06-30 | $186 |
| 2017-03-31 | $244 |
| 2016-12-31 | $260 |
| 2016-09-30 | $306 |
| 2016-06-30 | $308 |
| 2016-03-31 | $353 |
| 2015-12-31 | $326 |
| 2015-09-30 | $310 |
| 2015-06-30 | $300 |
| 2015-03-31 | $251 |
| 2014-12-31 | $257 |
| 2014-09-30 | $248 |
| 2014-06-30 | $179 |
| 2014-03-31 | $105 |
| 2013-12-31 | $112 |
| 2013-09-30 | $114 |
| 2013-06-30 | $104 |
| 2013-03-31 | $107 |
| 2012-12-31 | $99 |
| 2012-09-30 | $95 |
| 2012-06-30 | $86 |
| 2012-03-31 | $103 |
| 2011-12-31 | $86 |
| 2011-09-30 | $77 |
| 2011-06-30 | $73 |
| 2011-03-31 | $73 |
| 2010-12-31 | $80 |
| 2010-09-30 | $79 |
| 2010-06-30 | $74 |
| 2010-03-31 | $83 |
| 2009-12-31 | $67 |
| 2009-09-30 | $65 |
| 2009-06-30 | $62 |
| 2009-03-31 | $69 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $8.074B | $2.094B |
| Masimo Corporation develops, manufactures and markets a family of non-invasive monitoring systems. The Company has two segments: Product Revenues, Royalty & Other revenues. Within Product revenues, the company's flagship - Signal Extraction Tecgnology (SET) Pulse Oximetry - is used to monitor blood oxygen saturation levels and protect against hypoxemia and hyperoxemia. The device also measures pulse rate. Apart from blood monitoring, the company has also ventured into non-invasive blood constituent, brain and breathe monitoring. The company's rainbow Pulse CO-Oximetry measures blood constituents that include total hemoglobin (SpHb), oxygen content (SpOC), carboxyhemoglobin (SpCO), methemoglobin (SpMet) and SET measurements of oxygen saturation (SpO2), pulse rate (PR), perfusion index (PI), and pleth variability index (PVi). Rainbow Acoustic Monitoring measures respiration rate (RRa) non-invasively and on a continuous basis. SedLine monitors brain functioning of patients under anesthesia or sedation. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $188.802B | 22.84 |
| Intuitive Surgical (ISRG) | United States | $170.692B | 70.75 |
| IDEXX Laboratories (IDXX) | United States | $51.647B | 53.75 |
| Edwards Lifesciences (EW) | United States | $48.042B | 31.84 |
| Alcon (ALC) | Switzerland | $40.456B | 27.16 |
| IQVIA Holdings (IQV) | United States | $32.496B | 18.36 |
| DexCom (DXCM) | United States | $32.259B | 48.39 |
| Mettler-Toledo (MTD) | United States | $27.221B | 32.31 |
| STERIS (STE) | Ireland | $24.807B | 26.40 |
| Waters (WAT) | United States | $17.988B | 24.71 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.319B | 0.00 |
| Hologic (HOLX) | United States | $15.182B | 16.45 |
| Penumbra (PEN) | United States | $10.325B | 75.42 |
| Globus Medical (GMED) | United States | $8.444B | 19.48 |
| Sysmex ADR (SSMXY) | Japan | $8.410B | 26.72 |
| Teleflex (TFX) | United States | $5.719B | 9.23 |
| Glaukos (GKOS) | United States | $5.400B | 0.00 |
| TransMedics (TMDX) | United States | $4.086B | 62.10 |
| Integer Holdings (ITGR) | United States | $3.874B | 19.33 |
| LivaNova (LIVN) | United Kingdom | $3.052B | 17.47 |
| Veracyte (VCYT) | United States | $2.439B | 33.70 |
| Alphatec Holdings (ATEC) | United States | $2.388B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $2.294B | 0.00 |
| Artivion (AORT) | United States | $2.115B | 106.74 |
| Elekta AB (EKTAY) | Sweden | $1.924B | 18.00 |
| Nihon Kohden (NHNKY) | Japan | $1.914B | 22.85 |
| Integra LifeSciences Holdings (IART) | United States | $1.158B | 6.63 |
| Pulse Biosciences (PLSE) | United States | $1.147B | 0.00 |
| OPKO Health (OPK) | United States | $1.119B | 0.00 |
| IRadimed (IRMD) | United States | $0.924B | 44.85 |
| Tandem Diabetes Care (TNDM) | United States | $0.806B | 0.00 |
| AxoGen (AXGN) | United States | $0.748B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.741B | 0.00 |
| SiBone (SIBN) | United States | $0.707B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.575B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.543B | 9.60 |
| OrthoPediatrics (KIDS) | United States | $0.506B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.486B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.465B | 3.74 |
| Pacific Biosciences Of California (PACB) | United States | $0.415B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.401B | 10.20 |
| Delcath Systems (DCTH) | United States | $0.389B | 92.67 |
| AngioDynamics (ANGO) | United States | $0.384B | 0.00 |
| RxSight (RXST) | United States | $0.380B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.304B | 0.00 |
| NeuroPace (NPCE) | United States | $0.297B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.295B | 20.35 |
| Spectral Diagnostics (EDTXF) | Canada | $0.289B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.268B | 0.00 |
| 908 Devices (MASS) | United States | $0.231B | 0.00 |
| Neuronetics (STIM) | United States | $0.225B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.222B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.221B | 0.00 |
| Inogen (INGN) | United States | $0.210B | 0.00 |
| CVRx (CVRX) | United States | $0.204B | 0.00 |
| Accuray (ARAY) | United States | $0.179B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.175B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.163B | 0.00 |
| LENSAR (LNSR) | United States | $0.154B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.150B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.126B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.119B | 0.00 |
| Hyperfine (HYPR) | United States | $0.102B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.100B | 0.00 |
| InspireMD (NSPR) | United States | $0.099B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.082B | 0.00 | |
| QT Imaging Holdings (QTIH) | United States | $0.061B | 0.00 |
| Spectral AI (MDAI) | United States | $0.056B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.053B | 0.00 |
| Positron (POSC) | United States | $0.051B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.050B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.044B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.040B | 0.00 |
| Precision Optics (POCI) | United States | $0.038B | 0.00 |
| DarioHealth (DRIO) | United States | $0.026B | 0.00 |
| Envoy Medical (COCH) | United States | $0.025B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.020B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.019B | 0.00 |
| NexGel (NXGL) | United States | $0.019B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.015B | 0.00 |
| Tenon Medical (TNON) | United States | $0.013B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.010B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.009B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.007B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 13.55 |